title: Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial.
abstract: OBJECTIVE
  To examine the effect of intensive therapy on neuropsychological performance in patients who participated in the Diabetes Control and Complications Trial (DCCT).
  
  
  METHODS
  Multicenter, randomized, controlled clinical trial.
  
  
  METHODS
  29 DCCT clinical centers.
  
  
  METHODS
  1441 patients with insulin-dependent diabetes mellitus (IDDM) between 13 and 39 years of age who had had IDDM for 1 to 15 years and had no or minimal retinopathy or nephropathy at baseline. Volunteers were excluded if they had a history of substance abuse, psychological disturbance, or recurrent hypoglycemia with coma or seizure.
  
  
  METHODS
  Intensive therapy with 3 or more daily insulin injections or continuous subcutaneous insulin infusion, guided by 4 or more glucose tests per day, compared with conventional therapy with 1 or 2 daily insulin injections.
  
  
  METHODS
  Neuropsychological assessments were done at baseline; years 2, 5, and 7; and the end of the study. Eight cognitive domain scores were developed from the test results and were used to identify patients whose neuropsychological performance had clinically worsened.
  
  
  RESULTS
  Intensive therapy did not affect neuropsychological performance. In addition, patients who had repeated episodes of hypoglycemia did not perform differently than patients who did not have repeated episodes.
  
  
  CONCLUSIONS
  Intensive therapy and the attendant risk for hypoglycemia were not associated with neuropsychological impairment in the DCCT.
mesh_terms: D000293:Adolescent; D000328:Adult; D003072:Cognition Disorders / Q000209:etiology*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000188:drug therapy* / Q000523:psychology*; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007003:Hypoglycemia / Q000209:etiology; D007260:Infusion Pumps; D007267:Injections; D007328:Insulin / Q000008:administration & dosage*; D008297:Male; D009483:Neuropsychological Tests; D010349:Patient Compliance; D012044:Regression Analysis
chemical_list: D007328:Insulin